AGN Ann: First Healthy Adult Subject Dosed in Phase 1 Trial of ARG007 - 17th Oct 2022, 9:34am

annb0t

annb0t

Top 20
AGN Ann: First Healthy Adult Subject Dosed in Phase 1 Trial of ARG007
Price Sensitive: Y
Date: 17th Oct 2022, 9:34am

>>> Read announcement: Google: AGN Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
AGN Ann: Board Update - 27th Oct 2023, 11:43am
Replies
0
Views
121
annb0t
annb0t
annb0t
AGN Ann: Notice of Annual General Meeting/Proxy Form - 27th Oct 2023, 11:37am
Replies
0
Views
71
annb0t
annb0t
annb0t
AGN Ann: Quarterly Activities/Appendix 4C Cash Flow Report - 26th Oct 2023, 8:17am
Replies
0
Views
73
annb0t
annb0t
annb0t
AGN Ann: Investor Presentation - 25th Oct 2023, 11:26am
Replies
0
Views
63
annb0t
annb0t
annb0t
AGN Ann: Preclinical HIE Study - ARG007 Effective Stand-Alone Therapy - 18th Oct 2023, 8:19am
Replies
0
Views
63
annb0t
annb0t
Top Bottom